Cargando…

Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) Study: design of lifestyle intervention

INTRODUCTION: Intensive lifestyle intervention (ILI) prevents progression from prediabetes to type 2 diabetes (T2D) but reversal of prediabetes is less well studied. RESEARCH DESIGN AND METHODS: The overall objectives of the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-AB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagogo-Jack, Samuel, Brewer, Amy A, Owei, Ibiye, French, Lindsey, Umekwe, Nkiru, Rosenthal, Renate, Wan, Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292036/ https://www.ncbi.nlm.nih.gov/pubmed/32527719 http://dx.doi.org/10.1136/bmjdrc-2019-000899

Ejemplares similares

Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study
por: Dagogo-Jack, Samuel, et al.
Publicado: (2022)

Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort
por: Owei, Ibiye, et al.
Publicado: (2017)

Ethnic Disparities in Endothelial Function and Its Cardiometabolic Correlates: The Pathobiology of Prediabetes in A Biracial Cohort Study
por: Owei, Ibiye, et al.
Publicado: (2018)

Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study
por: Jiang, Yunna, et al.
Publicado: (2016)

Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC): Retention Strategies
por: Ebenibo, Sotonte, et al.
Publicado: (2013)

Plasma FGF-21 and Sclerostin Levels, Glycemia, Adiposity, and Insulin Sensitivity in Normoglycemic Black and White Adults
por: Umekwe, Nkiru, et al.
Publicado: (2021)

Parental history of type 2 diabetes is associated with lower resting energy expenditure in normoglycemic subjects
por: Nyenwe, Ebenezer A, et al.
Publicado: (2018)

Recruitment strategies and yields for the Pathobiology of Prediabetes in a Biracial Cohort: a prospective natural history study of incident dysglycemia
por: Ebenibo, Sotonte, et al.
Publicado: (2013)

Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2008)

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
por: Perreault, Leigh, et al.
Publicado: (2019)

Fitness, Fatness, and Survival in Adults With Prediabetes
por: McAuley, Paul A., et al.
Publicado: (2014)

Trajectories of Body Weight and Fat Mass in Relation to Incident Prediabetes in a Biracial Cohort of Free-Living Adults
por: Al Hommos, Nisreen Abu, et al.
Publicado: (2020)

Basal and Dynamic Leptin Secretion: Association with Cardiometabolic Risk and Body Weight Trajectories in African-Americans and European-Americans
por: Ebenibo, Sotonte, et al.
Publicado: (2018)

Gender-related affecting factors of prediabetes on its 10-year outcome
por: Song, Xiaomin, et al.
Publicado: (2016)

Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes
por: Sasaki, Nobuo, et al.
Publicado: (2020)

Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program
por: DeBoer, Mark D., et al.
Publicado: (2018)

Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
por: Perreault, Leigh, et al.
Publicado: (2014)

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
por: Perreault, Leigh, et al.
Publicado: (2022)

Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
por: Braffett, Barbara H., et al.
Publicado: (2019)

Association of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity: The Framingham Heart Study
por: Molenaar, Esther A., et al.
Publicado: (2009)

Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
por: Mathew, Anna V., et al.
Publicado: (2018)

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021)

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
por: Dagogo-Jack, Samuel, et al.
Publicado: (2021)

Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study
por: Hamdy, Osama, et al.
Publicado: (2017)

Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study
por: Tomah, Shaheen, et al.
Publicado: (2023)

Lower Hepatic Fat Is Associated With Improved Insulin Secretion in a High-Risk Prediabetes Subphenotype During Lifestyle Intervention
por: Wagner, Robert, et al.
Publicado: (2023)

Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy
por: Korytkowski, Mary T, et al.
Publicado: (2016)

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
por: Charytan, David M, et al.
Publicado: (2023)

Incidence of type 2 diabetes in familial combined hyperlipidemia
por: Brouwers, Martijn C G J, et al.
Publicado: (2020)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

Sounding Black or White: priming identity and biracial speech
por: Gaither, Sarah E., et al.
Publicado: (2015)

Prevalence of the Metabolic Syndrome Among a Racially/Ethnically Diverse Group of U.S. Eighth-Grade Adolescents and Associations With Fasting Insulin and Homeostasis Model Assessment of Insulin Resistance Levels
Publicado: (2008)

Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
por: Retnakaran, Ravi, et al.
Publicado: (2008)

Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
por: Tirosh, Amir, et al.
Publicado: (2008)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Changes in Risk Variables of Metabolic Syndrome Since Childhood in Pre-Diabetic and Type 2 Diabetic Subjects: The Bogalusa Heart Study
por: Nguyen, Quoc Manh, et al.
Publicado: (2008)

Alcohol Consumption, Mediating Biomarkers, and Risk of Type 2 Diabetes Among Middle-Aged Women
por: Beulens, Joline W.J., et al.
Publicado: (2008)

Predicting Diabetes: Clinical, Biological, and Genetic Approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR)
por: Balkau, Beverley, et al.
Publicado: (2008)

Normal Glucose Values Are Associated With a Lower Risk of Mortality in Hospitalized Patients
por: Bruno, Alberto, et al.
Publicado: (2008)

Hyperinsulinemia in African-American Adolescents Compared With Their American White Peers Despite Similar Insulin Sensitivity: A reflection of upregulated β-cell function?
por: Hannon, Tamara S., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_m92ijemkb2iups359ccui5gf6q